Skip to main content

Increasing Clinical Trial Participation Through Eligibility Expansion and Inclusivity Considerations

Watch the Webinar On-Demand

About the Webinar

In the last few years, greater attention is being paid toward ensuring that as many people as possible can participate in clinical research. The often-cited statistic that only 5% of cancer patients enroll in clinical trials doesn’t reflect that most non-participants have no trial options for which they are eligible. To open research participation, we need to consider both how we develop eligibility criteria in clinical protocols to allow the broadest possible range of participants, and we need to look at how we present and conduct trials, to make sure that they are welcoming and inclusive to everyone and to all communities.

In this webinar, our speakers will discuss:

  • Recommendations for the expansion of study eligibility criteria in trials to be more reflective of real-world populations
  • Suggestions to make clinical research more welcoming, with a specific focus on inclusion for the LGBTQIA+ community

Meet the Speakers

Photo of Dawn Flitcraft

Dawn Flitcraft (Moderator)

President, WCG IRB

Carl Streed Jr., MD, MPH

Assistant Professor of Medicine at Boston University School of Medicine

Dr. Streed is also Research Lead for the Center for Transgender Medicine and Surgery at Boston Medical Center.

Lindsay McNair, MD, MPH, MSB

Chief Medical Officer, WCG

Are you ready to transform the diversity of your clinical trials?

Use this form to request a consultation with WCG's Diversity, Equity & Inclusion experts.